Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004629742 | SCV005125716 | uncertain significance | Inborn genetic diseases | 2024-04-12 | criteria provided, single submitter | clinical testing | The c.91A>G (p.M31V) alteration is located in exon 2 (coding exon 1) of the GLIS3 gene. This alteration results from a A to G substitution at nucleotide position 91, causing the methionine (M) at amino acid position 31 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005040731 | SCV005677459 | uncertain significance | Neonatal diabetes mellitus with congenital hypothyroidism | 2024-05-31 | criteria provided, single submitter | clinical testing |